Overall, patients initiating exenatide b.i.d. reported a significantly shorter mean duration of diagnosed diabetes than those initiating insulin (8 ± 6 vs. 10 ± 7 years, respectively; P < 0.0001). Here, INS is linked to diabetes mellitus.